I-VIREX -Isizukulwana esilandelayo kuVavanyo lwe-Dx ekhaya kunye ne-PCR-level sensitivity ye-Daily Covid-19 Tests kunye ne-Cancer yasekuqaleni Dx
Ibonakalise ubuntununtunu obuphezulu kakhulu kubahlalutyi bebhayoloji abaninzi, kubandakanya:
- Ukufunyaniswa kwentsholongwane ye-COVID-19 kubuthathaka njenge-5 TCID50, ukukhuphisana nobuntununtunu bePCR
- Uvavanyo lwe-biomarker yomhlaza wesibindi kwangoko lufumanisa iprotein biomarker ekujoliswe kuyo kwi-5 microliters yegazi.
Uphuhliso lwemichiza kunye neprototyping ekulindeleke ukuba igqitywe kwi-Q3 2022 kunye novavanyo lwecandelo leprototype ukuze kungeniswe ulawulo kwi-Q3/Q4 2022.
Ngoyilo kunye nokubonelela okuphuhliswe ngokupheleleyo kuvavanyo lwesizukulwana sokuqala se-Virex Dx, ilayibrari ye-GMAB yase-Sorrento iya kuqeshwa ukuphuhlisa ngokukhawuleza kwaye ithumele iimvavanyo ezinobuthathaka kakhulu kwizifo ezininzi ezosulelayo kunye nezoyikiso zebhayoloji.
Iqonga leVirex libonelela ngamathuba okuphuhlisa ngokukhawuleza uvakalelo oluphezulu, olufikelelekayo kunye nolwenzekayo kwisizukulwana esilandelayo sovavanyo lokuxilonga izisombululo ze-COVID-19 nangaphaya ngokunyusa ikhemistri kunye neziseko zophuhliso lweemitha zeglucose kunye nemicu yovavanyo.
